Janux Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 03, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $56,000,000
Company Info
- Company Description
- Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
- Market
- Immunotherapy for cancer treatment
- Location
- La Jolla, California, USA
- Coinvestors
- Avalon Ventures, Bregua Corporation, Correlation Ventures, OrbiMed Advisors, RA Capital Management